| The Effect of Stevia Rebaudiana Extracts on Different Variables Related to Caries: an in Vitro and in Vivo Evaluation. (NCT01757990) | Università degli Studi di Sassari | 2012-03-01 |
| The Study of Metastatic Pancreatic Adenocarcinoma (NCT01415713) | National Health Research Institutes, Taiwan | 2012-03-01 |
| Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer (NCT01608646) | Xijing Hospital | 2012-03-01 |
| Preventive Effect of Proprioceptive Stimulation on Muscle Atrophy (NCT01641627) | University Hospital, Lille | 2012-03-01 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (NCT01528111) | Lexicon Pharmaceuticals | 2012-03-01 |
| Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors (NCT01509079) | HealthPartners Institute | 2012-03-01 |
| Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis (NCT01574872) | Tecno Sun SRL | 2012-03-01 |
| Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML) (NCT01488344) | University Hospital Muenster | 2012-03-01 |
| Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma (NCT01506596) | Vector Oncology | 2012-03-01 |
| Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD) (NCT01437878) | Actelion | 2012-03-01 |
| Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia (NCT01465230) | Yale University | 2012-03-01 |
| N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia (NCT01474395) | Nathan Kline Institute for Psychiatric Research | 2012-03-01 |
| NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT01486797) | TME Pharma AG | 2012-03-01 |
| A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus (NCT01561807) | Vertex Pharmaceuticals Incorporated | 2012-03-01 |
| Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI (NCT01541709) | Asan Medical Center | 2012-03-01 |
| Effect of Xylitol on Oral Microbiota in Children (NCT01528969) | Kuwait University | 2012-03-01 |
| Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients (NCT01588145) | Hanmi Pharmaceutical Company Limited | 2012-03-01 |
| Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand (NCT01609595) | Boston University | 2012-03-01 |
| Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers (NCT01502202) | National Cancer Center, Korea | 2012-03-01 |
| Anakinra in Hidradenitis Suppurativa (NCT01558375) | University of Athens | 2012-03-01 |
| Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma (NCT01519869) | Rachel Miller | 2012-03-01 |
| Are You Sitting Down: Cognitive Exectutive Function Task Comparison Between Seated and Standing Positions (NCT01641588) | University of Southampton | 2012-03-01 |
| Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device (NCT01541254) | Microvention-Terumo, Inc. | 2012-03-01 |
| 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC (NCT01791387) | Auckland District Health Board | 2012-03-01 |
| Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris (NCT01474798) | Janssen Research & Development, LLC | 2012-02-29 |
| Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers (NCT03061513) | Weill Medical College of Cornell University | 2012-02-28 |
| Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts (NCT01532102) | Anaconda Pharma | 2012-02-28 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827) | Roswell Park Cancer Institute | 2012-02-28 |
| Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) (NCT01576484) | Regeneron Pharmaceuticals | 2012-02-28 |
| Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy (NCT01540409) | Sarepta Therapeutics, Inc. | 2012-02-27 |
| Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) (NCT01472939) | Shire | 2012-02-27 |
| A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT01453205) | MedImmune LLC | 2012-02-27 |
| Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers (NCT01563302) | Ionis Pharmaceuticals, Inc. | 2012-02-27 |
| Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients (NCT01520519) | M.D. Anderson Cancer Center | 2012-02-27 |
| Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis (NCT01548729) | University Hospital, Strasbourg, France | 2012-02-25 |
| Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma (NCT01555281) | Swiss Cancer Institute | 2012-02-23 |
| A Study of Alirocumab in Participants With Autosomal Dominant Hypercholesterolemia (ADH) and Gain-of-Function Mutations (GOFm) of the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Gene or Loss-of-Function Mutations (LOFm) of the Apolipoprotein (Apo) B Gene (NCT01604824) | Regeneron Pharmaceuticals | 2012-02-22 |
| Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide (NCT01723839) | Hackensack Meridian Health | 2012-02-22 |
| Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer (NCT01507428) | National Cancer Institute (NCI) | 2012-02-22 |
| Collection of Transplant Stem Cells for Plasma Cell Myeloma (NCT01547806) | National Cancer Institute (NCI) | 2012-02-22 |
| Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer (NCT01543659) | Memorial Sloan Kettering Cancer Center | 2012-02-21 |
| Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer (NCT01620515) | Nymox Corporation | 2012-02-21 |
| A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009) (NCT01527383) | Merck Sharp & Dohme LLC | 2012-02-21 |
| Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma (NCT02481960) | Boston Scientific Corporation | 2012-02-21 |
| Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors (NCT01619865) | Sue O'Dorisio | 2012-02-21 |
| Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid (NCT01571895) | Dompé Farmaceutici S.p.A | 2012-02-20 |
| A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (NCT01491737) | Hoffmann-La Roche | 2012-02-17 |
| Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy (NCT01437488) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-02-16 |
| A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study (NCT01519778) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-02-15 |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer (NCT01525966) | City of Hope Medical Center | 2012-02-15 |
| Trial of pIL-12 Electroporation Malignant Melanoma (NCT01502293) | OncoSec Medical Incorporated | 2012-02-14 |
| Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma (NCT02272816) | Barts & The London NHS Trust | 2012-02-13 |
| Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype (NCT01534260) | Hamid Sayar | 2012-02-10 |
| Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT01535924) | Beth Christian | 2012-02-09 |
| Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell (NCT01660607) | Stanford University | 2012-02-09 |
| A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours (NCT01396408) | Canadian Cancer Trials Group | 2012-02-09 |
| AMG 386 and Abiraterone for Advanced Prostate Cancer (NCT01553188) | National Cancer Institute (NCI) | 2012-02-08 |
| Continuation Study of the Oral AKT Inhibitor GSK2110183 (NCT01531894) | Novartis Pharmaceuticals | 2012-02-08 |
| Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (NCT01410942) | M.D. Anderson Cancer Center | 2012-02-08 |
| Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) (NCT01515527) | M.D. Anderson Cancer Center | 2012-02-07 |
| A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes (NCT01725308) | Astellas Pharma Inc | 2012-02-07 |
| A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT01466153) | MedImmune LLC | 2012-02-07 |
| De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca (NCT01530997) | UNC Lineberger Comprehensive Cancer Center | 2012-02-07 |
| Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01498978) | OHSU Knight Cancer Institute | 2012-02-06 |
| A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020) (NCT01513291) | Merck Sharp & Dohme LLC | 2012-02-06 |
| A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (NCT01507168) | Hoffmann-La Roche | 2012-02-02 |
| Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD) (NCT01510028) | Shire | 2012-02-02 |
| Effect of Low-Level Laser on Pain and Healing of Donor Site Following Free Gingival Graft (NCT02896283) | Tehran University of Medical Sciences | 2012-02-01 |
| Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis (NCT01510613) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2012-02-01 |
| Gastric Plication and Banding (NCT02072395) | Ohio State University | 2012-02-01 |
| Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis (NCT01528813) | Brasilia University Hospital | 2012-02-01 |
| Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder (NCT01547702) | Dalhousie University | 2012-02-01 |
| Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure (NCT01873300) | Massachusetts General Hospital | 2012-02-01 |
| High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant (NCT01534143) | Barbara Ann Karmanos Cancer Institute | 2012-02-01 |
| Vitamin K2 Intervention in Patients With Vitamin K Antagonists (NCT01533441) | Danisco | 2012-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy (NCT01556568) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2012-02-01 |
| Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) (NCT01535950) | Novartis Pharmaceuticals | 2012-02-01 |
| Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma (NCT01497275) | Duke University | 2012-02-01 |
| Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial (NCT01876043) | Institut Bergonié | 2012-02-01 |
| Booster as an Adjunct to Internet-based Cognitive Behavior Therapy (CBT) (NCT01525576) | Karolinska Institutet | 2012-02-01 |
| Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (NCT02105675) | SOTIO a.s. | 2012-02-01 |
| Tocotrienols for School-going Children With ADHD (NCT01855984) | RCSI & UCD Malaysia Campus | 2012-02-01 |
| Bedside Sedation for the Prevention of Post Dural Puncture Headache (NCT01503788) | Tel-Aviv Sourasky Medical Center | 2012-02-01 |
| Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas (NCT01140360) | Kent Robertson | 2012-02-01 |
| Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma (NCT01501942) | AIM Therapeutics Inc. | 2012-02-01 |
| Effect of Febuxostat on Blood Pressure (NCT01496469) | Takeda | 2012-02-01 |
| Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma (NCT01534585) | Taizhou Hospital | 2012-02-01 |
| Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients (NCT01370408) | Northside Hospital, Inc. | 2012-02-01 |
| A Randomized Control Trial of Sun Protection Interventions for Operating Engineers (NCT01804595) | University of Michigan | 2012-02-01 |
| Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure (NCT01544998) | Mayo Clinic | 2012-02-01 |
| Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone (NCT01428219) | University of Michigan Rogel Cancer Center | 2012-02-01 |
| Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients (NCT01530373) | University of Arkansas | 2012-02-01 |
| Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool (NCT01699711) | Parc de Salut Mar | 2012-02-01 |
| Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus (NCT01603121) | Eastern Virginia Medical School | 2012-02-01 |
| Conservative Treatments of Retinoblastoma (NCT02866136) | Institut Curie | 2012-02-01 |
| Perioperative Chemotherapy for Potentially Resectable Gastric Cancer (NCT01516944) | Hebei Medical University | 2012-02-01 |
| Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease (NCT01702246) | UCSF Benioff Children's Hospital Oakland | 2012-02-01 |
| Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS (NCT01723683) | China Medical University Hospital | 2012-02-01 |
| Atacicept Demonstrating Dose RESponSe (NCT01440231) | EMD Serono | 2012-02-01 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects (NCT01563536) | AbbVie (prior sponsor, Abbott) | 2012-02-01 |